Share this article and save a life!
CMS just made your routine chest CT a cardiac screening tool.
And most imaging centers do not realize what that means for their revenue, or their patients.
Starting April 1, 2026, health systems and imaging centers can bill Medicare for AI-powered detection of coronary artery calcium and aortic valve calcium found incidentally on chest CTs. Bunkerhill Health was first to secure this reimbursement pathway, and the implications are enormous.
Here is the part that matters most.
More than 20 million chest CTs are performed in the U.S. every year. The vast majority are ordered for pulmonary or oncological reasons, not cardiac ones. But heart disease is hiding in those scans. AI can now find it automatically, flag the risk, and your team can bill for it.
That is not a minor billing update. That is a structural shift in how preventive cardiology gets delivered.
🫀 What makes this different from prior cardiac screening efforts:
Traditional coronary calcium scoring requires a dedicated low-dose CT scan ordered specifically for cardiac risk. Patients have to show up for it. Doctors have to think to order it. Underserved populations rarely get it.
Opportunistic screening flips the model entirely. The patient is already in the scanner. The AI runs in the background. The finding surfaces automatically. No extra visit, no extra order, no extra cost to the patient.
For FQHCs and community health centers, this matters even more. Your patients are less likely to get elective cardiac screening. They are more likely to have undiagnosed cardiovascular disease. If you have a CT program or a radiology partnership, opportunistic AI screening is one of the most equitable preventive tools now available to you.
📋 What imaging centers and health systems should be asking right now:
Is your AI vendor cleared for coronary and aortic valve calcium detection? Not all chest CT AI tools cover this. Clearance and billing eligibility are two different hurdles.
Is your radiology workflow set up to surface and act on incidental cardiac findings? Detection without a follow-up pathway is a liability, not a feature.
Are your billing and compliance teams aware of the new code structure? This is still new territory and documentation requirements matter.
Do your referring providers know this capability exists? Most primary care physicians do not yet know their patients could get a cardiac risk flag from a chest CT they already ordered.
The economics here are straightforward. A chest CT that already covers its cost now generates an additional billable finding, without additional radiation, without rescheduling, and without added patient burden.
The clinical case is even stronger. Coronary artery calcium is one of the most validated predictors of cardiovascular events. Getting that data in front of a provider while a patient is already engaged in care is exactly what preventive medicine is supposed to look like.
The bigger question for health system leaders is this: how many of your patients already had calcium hiding in their scans over the last five years, and no one ever flagged it because the billing pathway did not exist?
That window is now open. The question is whether your organization is ready to walk through it.
♻️ Repost if every chest CT should be working harder for your patients.
👉 Follow me for daily healthcare updates and get the deeper analysis in my Substack newsletter → https://lnkd.in/eJKFuB_p
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
